Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system: Long-term follow-up of a randomised control trial
- 30 September 2009
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 114 (3), 452-456
- https://doi.org/10.1016/j.ygyno.2009.06.014
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cytochrome P450 2D6 and Homeobox 13/Interleukin-17B Receptor: Combining Inherited and Tumor Gene Markers for Prediction of Tamoxifen ResistanceClinical Cancer Research, 2008
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatmentBritish Journal of Cancer, 2003
- Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoringEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2002
- Endometrial Histopathology in 700 Patients Treated with Tamoxifen for Breast CancerGynecologic Oncology, 2000
- Malignant Endometrial Polyps in Postmenopausal Breast Cancer Tamoxifen-Treated PatientsGynecologic Oncology, 1999
- Endometrial cancer in polyps associated with tamoxifen useAmerican Journal of Obstetrics and Gynecology, 1999
- Endometrial PolypsInternational Journal of Gynecological Pathology, 1998
- Uterine Side Effects of Tamoxifen: A Need for Systematic Pretreatment ScreeningObstetrics & Gynecology, 1998
- Pathology of endometrium treated with tamoxifen.Journal of Clinical Pathology, 1994